aid: abogen
name: Abogen
description: 'Abogen Biosciences (Suzhou Abogen Biosciences Co., Ltd. / 苏州艾博生物科技有限公司)
  is a clinical-stage biotechnology company founded in January 2019 and headquartered in Suzhou, China,
  dedicated to developing transformative medicines through messenger RNA (mRNA) innovation. The company
  has built full-scale in-house capabilities spanning the entire mRNA drug development cycle - protein
  engineering, mRNA sequence design and synthesis, proprietary lipid nanoparticle (LNP) delivery,
  formulation, and commercial-scale manufacturing. Its product pipeline covers infectious disease
  prevention and cancer immunotherapy, and it has advanced an EUA mRNA product along with additional
  clinical-stage candidates. Abogen is a portfolio company of the SoftBank Vision Fund. Abogen is a
  pharmaceutical / biotechnology company and does not currently publish a public developer platform,
  API, or SDK; this profile captures its corporate identity in the API Evangelist network.'
url: https://raw.githubusercontent.com/api-evangelist/abogen/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- softbank-vision-fund
x-tier: stub
x-tier-reason: portfolio-lead
x-api-surface: none
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
image: https://abogenbio.com/assets/img/logo.png
tags:
- Company
- Health Tech
- Biotechnology
- Pharmaceuticals
- mRNA
- Therapeutics
- Drug Development
- Life Sciences
apis: []
common:
- type: Website
  name: Abogen Biosciences Website
  url: https://abogenbio.com/
- type: PrivacyPolicy
  name: Privacy Policy
  url: https://abogenbio.com/privacy/
- type: Support
  name: Contact Us
  url: https://abogenbio.com/contact/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence